- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical development of mTOR inhibitors in breast cancer ; volume:16 ; number:1 ; day:17 ; month:2 ; year:2014 ; pages:1-9 ; date:2.2014
Breast cancer research ; 16, Heft 1 (17.2.2014), 1-9, 2.2014
- Urheber
-
Vicier, Cecile
- Beteiligte Personen und Organisationen
-
Dieci, Maria Vittoria
Arnedos, Monica
Delaloge, Suzette
Viens, Patrice
Andre, Fabrice
SpringerLink (Online service)
- DOI
-
10.1186/bcr3618
- URN
-
urn:nbn:de:1111-2016032419049
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vicier, Cecile
- Dieci, Maria Vittoria
- Arnedos, Monica
- Delaloge, Suzette
- Viens, Patrice
- Andre, Fabrice
- SpringerLink (Online service)
Ähnliche Objekte (12)
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Deptor: not only a mTOR inhibitor
mTor Inhibitors for the Treatment of Endometriosis
mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
Practical considerations for the use of mTOR inhibitors
Perfect match: mTOR inhibitors and tuberous sclerosis complex
Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model
mTOR inhibition in management of advanced breast cancer
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Deptor: not only a mTOR inhibitor
mTor Inhibitors for the Treatment of Endometriosis
mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
Practical considerations for the use of mTOR inhibitors
Perfect match: mTOR inhibitors and tuberous sclerosis complex
Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model
mTOR inhibition in management of advanced breast cancer
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Deptor: not only a mTOR inhibitor
mTor Inhibitors for the Treatment of Endometriosis
mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
Practical considerations for the use of mTOR inhibitors
Perfect match: mTOR inhibitors and tuberous sclerosis complex
Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model